FDA Adverse Event Injury Summary report: N

VERSAPOINT ELECTRODE UNKNOWN PRODUCT

MDR report key: 9183748 · Received October 14, 2019

Report

Report Number
2210968-2019-88607
Event Type
Injury
Date Received
October 14, 2019
Report Date
September 16, 2019
Manufacturer
ETHICON INC.
Product Code
HIH
PMA / PMN Number
K040302
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). ADDITIONAL INFORMATION: CONCOMITANT PRODUCT - VERSAPOINT GENERATOR.

Additional Manufacturer Narrative · 1

(B)(4). THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS THROUGH A JOURNAL ARTICLE. NO SPECIFIC PATIENT INFORMATION REGARDING EVENTS HAS BEEN PROVIDED AND IT IS UNKNOWN IF THE EVENTS HAVE BEEN PREVIOUSLY REPORTED. THE MANUFACTURING RECORD EVALUATION CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED IN A JOURNAL ARTICLE ENTITLED: TRANSCERVICAL INCISION OF SEPTA. THIS RETROSPECTIVE STUDY AIMED TO EVALUATE FEASIBILITY AND CLINICAL VALUE OF HYSTEROSCOPIC BIPOLAR ELECTRIC VAPORIZATION TECHNIQUE (VERSAPOINT BIPOLAR ELECTROSURGICAL SYSTEM) USED IN TRANSCERVICAL INCISION OF SEPTA (TCIS) IN AN OUTPATIENT SETTING. FROM (B)(6) 2001 TO (B)(6) 2005, 447 PATIENTS WITH AN AVERAGE AGE OF 29.17 ± 4.34 YEARS (RANGE 21¿53 YEARS) UNDERWENT HYSTEROSCOPIC TCIS. MICROSCISSORS WAS USED FOR 55 PATIENTS, MONOPOLAR ELECTRIC NEEDLE WAS USED FOR 15 PATIENTS, MONOPOLAR ELECTRIC LOOP WAS USED FOR 11 PATIENTS AND BIPOLAR ELECTRIC VAPORIZATION ELECTRODE WAS USED FOR 366 PATIENTS. BIPOLAR ELECTRIC RESECTOSCOPE (JOHNSON & JOHNSON INC., USA) AND VERSAPOINT BIPOLAR ELECTROSURGICAL SYSTEM (GYNECARE; ETHICON INC., NJ, USA) INCLUDED SPECIAL BIPOLAR ELECTRICAL GENERATOR WITH AN OUTPUT POWER AT 40¿60 W AND TWO TYPES OF EVAPORATION ELECTRODES: HELICAL ELECTRODE AND SPRING ELECTRODE (1.7 MM OUTER DIAMETERS) WITH THE FORMER USED IN ACCURATE VAPORIZATION INCISION AND THE LATTER USED IN DIFFUSE TISSUE VAPORIZATION. COMPLICATIONS INCLUDED UTERINE PERFORATION WHICH WAS TREATED WITH UTERINE CONTRACTION AGENTS; BLOOD LOSS AND INJURY TO BLOOD VESSELS IN MUSCULAR TISSUE OF UTERINE FUNDUS WHICH WERE TREATED WITH UTERINE CONTRACTION AGENTS AND HEMOSTATICS; POSTOPERATIVE PELVIC INFECTION AND URETHRAL INFECTION WHICH WERE TREATED WITH ANTIBIOTICS. IN CONCLUSION, HYSTEROSCOPIC BIPOLAR ELECTRIC VAPORIZATION TCIS COULD BE CARRIED OUT SAFELY AND EFFICACIOUSLY IN AN OUTPATIENT SETTING, BY USING SMALLER HYSTEROSCOPE AND BIPOLAR ELECTRODES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
980449 VERSAPOINT ELECTRODE UNKNOWN PRODUCT HYSTEROSCOPE (AND ACCESSORIES) HIH ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention VERSAPOINT GENERATOR UNKNOWN PRODUCT